Skip to content

Inspection of the Colon Using a Retrograde Viewing Device for Detection of Colorectal Polyps

Inspection of the Colon Using a Retrograde Viewing Device for Detection of Colorectal Polyps

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04107376
Enrollment
100
Registered
2019-09-27
Start date
2018-12-01
Completion date
2019-09-30
Last updated
2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma, Polyps

Keywords

retroviewing, endoscopy, adenoma detection, polyp detection

Brief summary

During standard colonoscopy a substantial number of colorectal polyps may be missed. Previous studies have found a 12-28% of miss rate for all polyps, a 31% for hyperplastic polyps and 6-27% for adenomas. In this study it is tested whether a retro viewing endoscope can detect more colorectal polyps in comparisson to standard forward viewing endoscopy. Further, ppolyps detected, mean adenomas per Patient and withdrawal time are recorded.

Interventions

DIAGNOSTIC_TESTRetroviewing endoscopy

The colon is inspected with a new retroviewing endoscope

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* screening colonoscopy * 18 years of age

Exclusion criteria

* inflammatory bowel disease * inadequate bowel preparation

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rate8 monthscalculation of the adenoma detection rate in each arm

Secondary

MeasureTime frameDescription
Polyp detection rate8 monthspolyp detection rate in each arm
Mean number of adenomas per patient8 monthsMean number of adenomas per patient in each arm
Withdrawal time8 monthsWithdrawal time in each arm

Countries

Germany

Contacts

Primary ContactTimo Rath, MD
timo.rath@uk-erlangen.de+49 9131 85 35000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026